Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31.2Revenue $M16.0Net Margin (%)-94.9Altman Z-Score-2.9
Enterprise Value $M26.3EPS $-0.4Operating Margin %-97.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-97.4Higher ROA y-yY
Price/Book0.810-y EBITDA Growth Rate %-11.0Quick Ratio1.3Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %-12.7Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-27.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-35.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M40.5ROIC % (ttm)-46.7Gross Margin Increase y-yN

Gurus Latest Trades with KOOL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KOOLKen Fisher 2011-09-30 Sold Out -0.0001%$1.2 - $2.13
($1.73)
$ 0.77-55%Sold Out0
KOOLKen Fisher 2011-06-30 Buy $1.91 - $2.47
($2.2)
$ 0.77-65%New holding20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KOOL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


KOOL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rhein Denis MichaelDirector 2014-12-01Sell0$0 view
ENGLE J MELVILLEChairman & CEO 2011-03-10Buy22,500$2.3-66.52 view
ARTILES JORGEVP, Quality/Regulatory Affairs 2010-01-13Buy100$2.44-68.44 view
ENGLE J MELVILLECEO 2009-09-25Buy25,000$2.28-66.23 view
MCENANY PATRICK JDirector 2009-05-19Buy6,250$2.32-66.81 view
ENGLE J MELVILLECEO 2009-05-12Buy25,000$2.2-65 view
MCENANY PATRICK JDirector 2009-05-08Buy6,250$2.12-63.68 view
HUCKEL HUBERT E MDDirector 2007-11-16Buy36,500$7.8-90.13 view
SEGAL DANIELVP Sales & Marketing 2007-03-01Buy750$12.56-93.87 view
COELHO PHILIP HCEO 2006-05-12Buy6,250$16.04-95.2 view

Quarterly/Annual Reports about KOOL:

News about KOOL:

Articles On GuruFocus.com
comment on KOOL Dec 01 2011 
comment on KOOL Aug 26 2011 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 11 2011 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Feb 04 2010 
THERMOGENESIS Corp. Reports Operating Results (10-Q) Nov 09 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares Sep 28 2009 
THERMOGENESIS Corp. (KOOL) CEO J Melville Engle buys 100,000 Shares May 12 2009 
THERMOGENESIS Corp. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
CESCA THERAPEUTICS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 29 2015
CESCA THERAPEUTICS REPORTS THIRD QUARTER FISCAL 2015 RESULTS Jun 29 2015
CESCA THERAPEUTICS INC. Financials Jun 27 2015
10-Q for Cesca Therapeutics, Inc. Jun 26 2015
10-Q for Cesca Therapeutics, Inc. Jun 25 2015
CESCA THERAPEUTICS INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 25 2015
Cesca Therapeutics Announces Compliance With Nasdaq Stock Market Under Listing Rule 5250(c)(1) Jun 25 2015
CESCA THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report Jun 24 2015
Cesca Therapeutics gets patent, approval to start clinical trial Jun 23 2015
CESCA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jun 23 2015
Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results Jun 23 2015
Cesca Therapeutics Announces Issuance of New U.S. Patent Jun 23 2015
Q3 2015 Cesca Therapeutics Inc Earnings Release - Time Not Supplied Jun 23 2015
Cesca Therapeutics Announces Issuance of New U.S. Patent Jun 23 2015
CESCA THERAPEUTICS TO ANNOUNCE THIRD QUARTER FISCAL 2015 RESULTS ON JUNE 23, 2015 Jun 17 2015
Cesca Therapeutics to Announce Third Quarter Fiscal 2015 Results on June 23, 2015 Jun 17 2015
Cesca Therapeutics Receives FDA IDE Approval for U.S. Pivotal Clinical Trial in Critical Limb... Jun 16 2015
CESCA THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 15 2015
Cesca's interim CEO takes permanent position as company faces challenges Jun 12 2015
CESCA THERAPEUTICS BOARD OF DIRECTORS APPOINT ROBIN C. STRACEY AS CHIEF EXECUTIVE OFFICER Jun 12 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK